Dimensional Fund Advisors
XERS icon

Dimensional Fund Advisors’s Xeris Biopharma Holdings XERS Stock Holding History

Dimensional Fund Advisors’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-48,663
Closed -$109K – 3396
2024
Q2 		$109K Sell
48,663
-6,437
-12% -$13K ﹤0.01% 3241
2024
Q1 		$122K Buy
+55,100
New +$143K ﹤0.01% 3241
2022
Q3 		– Sell
-45,082
Closed -$69K – 3532
2022
Q2 		$69K Buy
45,082
+5,688
+14% +$12K ﹤0.01% 3369
2022
Q1 		$101K Sell
39,394
-30,478
-44% -$74.5K ﹤0.01% 3393
2021
Q4 		$204K Buy
69,872
+21,402
+44% +$46.2K ﹤0.01% 3338
2021
Q3 		$119K Sell
48,470
-31,717
-40% -$92.1K ﹤0.01% 3410
2021
Q2 		$326K Buy
+80,187
New +$306K ﹤0.01% 3247

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Dimensional Fund Advisors's XERS Position: Q3 2024 in Review

Dimensional Fund Advisors sold out of Xeris Biopharma Holdings (XERS) in Q3 2024, closing a stake of 48,663 shares — an estimated $109K sold.

Dimensional Fund Advisors first reported a position in XERS in Q2 2021 and held it in 7 quarters. The position peaked at $326K in Q2 2021. 144 funds tracked by Wall St. Rank hold XERS as of Q3 2024.

  • Dimensional Fund Advisors reported no remaining Xeris Biopharma Holdings position as of Q3 2024 after selling out during the quarter.
  • Dimensional Fund Advisors sold 48,663 Xeris Biopharma Holdings shares in Q3 2024, an estimated $109K.
  • Dimensional Fund Advisors first reported a position in Xeris Biopharma Holdings in Q2 2021 and held it in 7 quarters.
  • Dimensional Fund Advisors's Xeris Biopharma Holdings position peaked at $326K in Q2 2021.
  • 144 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2024.

Based on Dimensional Fund Advisors's 13F filing for Q3 2024, filed 7 Nov 2024.